Percutaneous Mechanical Circulatory Support Devices Market to 2028
The percutaneous mechanical circulatory support devices market was valued at US$ 1,474.28 million in 2019 and is projected to reach US$ 3,964.75 million by 2027; it is expected to grow a ta CAGR of 13.5% during 2020–2027.
Percutaneous mechanical circulatory support devices offers an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices includeimproving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.
Market Insights
Rising Geriatric Population
The high market growth is anticipated on account of the rising global geriatric population. In both male and female population, the risk of cardiovascular diseases increases with an increase in age. Aging blood vessels are less flexible,leading to reducedblood flow. Thus, the risk of heart disease is high in the elderly population. Also, according to the Heart Disease and Stroke Statistics 2018, the average age at the first heart attack is 65.6 years for males and 72.0 years for females. It also mentioned that the annual incidence of a heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks. Moreover, according to the National Institutes of Health (NIH), America’s 65-and-over population is projected to nearly double over the next three decades, from 48 million to 88 million by 2050. Cardiovascular disease (CVD) in older Americans imposes a huge burden in terms of mortality, morbidity, disability, functional decline, and healthcare costs. A retrospective study performed by the University of Pittsburgh in 2015 states that the prevalence of CVD, including hypertension, CHD, HF, and stroke, increases from about 40% in men and women 40–59 years and 70-75% in persons aged 60–79 years, and 79–86% among those aged 80 years or older. Thus, the growing geriatric population leading to higher risks of heart failures and cardiogenic shocks increases the applications of percutaneous mechanical circulatory support devices and eventually favors market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Percutaneous Mechanical Circulatory Support Devices Market: Strategic Insights
Percutaneous Mechanical Circulatory Support Devices Market
-
CAGR (2019 - 2027)
13.5%
-
Market Size 2019
US$ 1.47 Billion
-
Market Size 2027
US$ 3.96 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Abbott
- Medtronic
- Getinge AB
- Teleflex Incorporated
- Livanova Plc Cardiacassist Inc
- Abiomed
- Eurosets
- Berlin Heart
- Jarvik Heart Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Intra-Aortic Balloon Pumps
- VA-Extracorporeal Membrane Oxygenators
Short-Term Ventricular Assist Devices)
End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South and Central America
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Percutaneous Mechanical Circulatory Support Devices Market: Strategic Insights
-
CAGR (2019 - 2027)13.5% -
Market Size 2019
US$ 1.47 Billion -
Market Size 2027
US$ 3.96 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Abbott
- Medtronic
- Getinge AB
- Teleflex Incorporated
- Livanova Plc Cardiacassist Inc
- Abiomed
- Eurosets
- Berlin Heart
- Jarvik Heart Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Intra-Aortic Balloon Pumps
- VA-Extracorporeal Membrane Oxygenators
- Hospitals
- Ambulatory Surgical Centers
- Others
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South and Central America
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Product-Based Market Insights
The product segment of the percutaneous mechanical circulatory support devices market is segmented into intra-aortic balloon pumps, VA-extracorporeal membrane oxygenation, and short-term ventricular assist devices. The intra-aortic balloon pumps segment held the largest share of the percutaneous mechanical circulatory support devices market in 2019. The short-term ventricular assist devices segment is anticipated to grow at aCAGR of 14.0% during the forecast period.EndUser-Based MarketInsights
The end user segment of the percutaneous mechanical circulatory support devices market is segmented hospitals, ambulatory surgical centers, and others. The hospitals segment heldthe largest shareof the percutaneous mechanical circulatory support devices market in 2019. The segment is also anticipated to grow at a CAGR of 14.2% during the forecast period.Additionally, the market players operating in the percutaneous mechanical circulatory support devices marketadopt the strategy ofexpansion to enlarge customer base across the world, which permits the players to maintain their brand name globally. For instance, in June 2016, Medetronic launched a product—Beacon, a care management service for high-risk heart failure patients. This service combines data from Medtronic implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) devices with post-acute monitoring from MCMS.
Percutaneous Mechanical Circulatory Support Devices Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 1.47 Billion |
Market Size by 2027 | US$ 3.96 Billion |
Global CAGR (2019 - 2027) | 13.5% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Global Percutaneous Mechanical Circulatory Support Devices Market – ByProduct
- Intra-Aortic Balloon Pumps
- VA-Extracorporeal Membrane Oxygenation (ECMO)
- Oxygenators
- Short-Term Ventricular Assist Devices (VADs)
- Impella
- Tandem Heart
Global Percutaneous Mechanical Circulatory Support DevicesMarket – By EndUser
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Percutaneous Mechanical Circulatory Support Devices– By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East &Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America (SAM)
- Brazil
- Argentina
- Rest of SAM
Company Profiles
- Abbott.
- Medtronic
- Getinge AB
- Teleflex Incorporated
- LivanovaPlc (Cardiacassist, Inc.).
- Abiomed
- Eurosets
- Berlin Heart
- Jarvik Heart, Inc.
- CardioBridge GmbH
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; End User ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The North American region holds the largest market for the breast cancer screening. The United States held the largest market for percutaneous mechanical circulatory support devices market and is expected to grow due to factors such as increasing number ofincreasing prevalence of cardiovascular diseases & heart failures, growing developments for screening and imaging process by the companies and others.
The growth of the market is attributed to some key driving factors such as rising geriatric population, increasing prevalence of cardiovascular diseases & heart failures however, impact of COVID-19 pandemic on medical device industry and high cost of products and procedures is expected to restraint the growth of the market during the forecast years.
The percutaneous mechanical circulatory support devices market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the percutaneous mechanical circulatory support devices market are present globally and have wide distribution and sales network through partnerships or authorized dealers.
The List of Companies - Percutaneous Mechanical Circulatory Support Devices Market
- Abbott.
- Medtronic
- Getinge AB
- Teleflex Incorporated
- Livanova Plc (Cardiacassist, Inc.).
- Abiomed
- Eurosets
- Berlin Heart
- Jarvik Heart, Inc.
- CardioBridge GmbH